Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328705 · ClinicalTrials.gov registry record · NA
D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management
A NA study of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 5
- Study locations
NCT00328705: Completed NA study of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00328705 is a NA study of Heart Diseases that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 65 participants, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00328705, a NA study of Heart Diseases, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.
Conditions Studied
Interventions
- DEVICE Implantable Cardioverter Defibrillator
Study Locations (5)
Minnesota
- - Coon Rapids
- - Rochester
- - Saint Paul
Florida
- - Tampa
North Carolina
- - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-01 |
| Phase | NA |
What the finished NCT00328705 record still lists
NCT00328705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Implantable Cardioverter Defibrillator is the first listed.
NCT00328705 lists 5 locations in 3 states (Minnesota, Florida, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00328705 about?
NCT00328705 is a clinical study titled "D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management". This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.
What is the current status of trial NCT00328705?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2006-05. Estimated completion is 2007-01.
What conditions does trial NCT00328705 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT00328705?
The interventions under investigation include: Implantable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00328705?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00328705 being conducted?
This trial has 5 study locations across Florida, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00328705's enrollment target sits among peer trials
65 73rd of 85 higher than 13 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia